PRESS-RELEASE ·Filed Apr 21, 2026

ISRG

Intuitive Surgical, Inc.
BULLISH
Impact 8/10
Horizonimmediate Processed6mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight ▲ Bullish

The strong beat and sustained guidance reinforce confidence in Intuitive's growth trajectory; traders should monitor upcoming procedure volume trends and international adoption of da Vinci 5 as key drivers.

DirectionBullish
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
ISRG ▼ -16.77% at T+60d
LONG call ✗ call lost -16.77% · α vs SPY -22.33% · entry $483.42 → $402.33
Entry anchored
Apr 21, 04:36 PM ET
via exchange tick
T+1d
-1.03%
call -1.03% · α -0.63%
$478.45
settled 6mo ago
T+5d
-6.60%
call -6.60% · α -6.65%
$451.52
settled 6mo ago
T+20d
-8.65%
call -8.65% · α -11.82%
$441.58
settled 5mo ago
T+60d
-16.77%
call -16.77% · α -22.33%
$402.33
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Intuitive Surgical reported Q1 2026 revenue of $2.77B (23% YoY growth) and non-GAAP EPS of $2.50, beating consensus estimates of $2.11 by 18.7%. The beat was driven by strong da Vinci and Ion procedure growth and higher system placements, while management maintained full-year 2026 guidance for 13.5%-15.5% procedure growth.

Key Financial Metrics

EPS
$2.50
est $2.11 · +18.5%
Revenue
$2.8B
est $2.6B · +5.7% · +23.0% YoY
Rating
strong beat
Gross Margin
66.1%

Key Facts

  • Q1 2026 revenue: $2.77B, up 23% YoY vs. $2.25B in Q1 2025
  • Non-GAAP EPS: $2.50, beating consensus of $2.11 by 18.7%
  • Da Vinci procedures grew 16%, Ion procedures grew 39%
  • Company placed 431 da Vinci systems (232 were da Vinci 5), up from 367 in Q1 2025
  • Repurchased 2.3M shares for $1.1B during the quarter

Financial Impact

Revenue beat by $150M ($2.77B actual vs. $2.62B consensus), EPS beat by $0.39

revenueepsoperating_incomecash_flow

Risk Factors

  • Tariff impacts could pressure gross margins if additional U.S. trade actions are implemented
  • Forward-looking non-GAAP guidance excludes unpredictable items like legal outcomes and tax adjustments

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
71% bullish (41 analysts)

Investment Themes

Healthcare & Medical DevicesRobotics & Automation

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3278489
24 reports for ISRG
Performance horizon
71% Hit rate 5 of 7 directional calls best @ T+60▲ +23.80%Jul 16, 2026
Filters
Rows
Reports for ISRG — sortable, filterable
TypeNow
Oct 7, 2026
11d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$414.52 $422.06▲ +1.82%▲ +1.72%$426.70 (+2.94%)
Sep 16, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$382.29 $398.30▲ +4.19%▲ +1.62%$426.70 (+11.62%)
Aug 19, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$374.48 $367.07▼ −1.98%▼ −3.09%$426.70 (+13.94%)
Aug 13, 2026
9w ago
Court Ruling
BEARISH ★ 7/10
$401.27 $374.48▲ +6.68%▲ +4.71%$426.70 (−6.34%)
Aug 12, 2026
9w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$401.27 $397.72▼ −0.88%▼ −0.44%$426.70 (+6.34%)
Aug 12, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$401.27 $397.72▼ −0.88%▼ −0.44%$426.70 (+6.34%)
Aug 11, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$401.27 $397.72▼ −0.88%▼ −0.44%$426.70 (+6.34%)
Jul 30, 2026
11w ago
ANALYST-DOWNGRADE
MIXED ★ 2/10
$352.97 $373.71▲ +5.88%▲ +2.25%$426.70 (+20.89%)
Jul 16, 2026
13w ago
Press Release
BULLISH ★ 6/10
$345.42 $332.02▼ −3.88%▼ −3.19%$426.70 (+23.53%)
Jul 9, 2026
14w ago
ANALYST-UPGRADE
MIXED ★ 3/10
$411.55 $402.33▼ −2.24%▼ −2.11%$426.70 (+3.68%)
Showing 10 of 24

US Market Status

Market Closed — Opens in 5h 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 21, 2026